Peter G. Linde
Corporate Officer/Principal bij Walden Biosciences, Inc.
Profiel
Peter G.
Linde is Chief Medical Officer for Walden Biosciences, Inc.
In his past career Dr. Linde was Chief Medical Officer of Morphic Holding, Inc., Senior Director-Clinical Development at FibroGen, Inc. and Vice President-Medical Research at Acceleron Pharma, Inc.
Peter G.
Linde received an undergraduate degree from Massachusetts Institute of Technology.
Actieve functies van Peter G. Linde
Bedrijven | Functie | Begin |
---|---|---|
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 11-10-2022 |
Eerdere bekende functies van Peter G. Linde
Bedrijven | Functie | Einde |
---|---|---|
MORPHIC HOLDING, INC. | Chief Tech/Sci/R&D Officer | 31-12-2021 |
FIBROGEN, INC. | Corporate Officer/Principal | - |
ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Opleiding van Peter G. Linde
Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
FIBROGEN, INC. | Health Technology |
MORPHIC HOLDING, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Health Services |